Leading United Kingdom Research Institution Standardizes on Heliospectra LX60 series
(GOTHENBURG, Sweden/SAN FRANCISCO, CA, July 31, 2017 –
Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from John Innes Centre in Norwich, United Kingdom. An independent, international centre of excellence in plant science, research, genetics and microbiology, the John Innes Centre order is valued at
£ 92,248 (1 048 273 SEK).
“Helisopectra’s collaboration with one of Europe’s leading research institutions presents the opportunity for our teams of plant science experts to advance commercial greenhouse applications,” said Ali Ahmadian, CEO of Heliospectra. “The innovative use of LED technologies optimizes plant health, nutritional profiles and crop quality. The research results and knowledge shared support a sustainable future for communities across the globe.”
John Innes Centre’s order of Heliospectra LX60 series lamps offers a holistic and flexible solution with adjustable spectra, intelligent LED lights that integrate with the company’s recently announced CORTEX software control to improve operations, research quality and production yields for scientists and cultivars.
Join the Heliospectra conversation:
Read more at www.heliospectra.com/blog
Follow @Heliospectra on Twitter
Like Heliospectra on Facebook at facebook.com/heliospectra
Ali Ahmadian, CEO of Heliospectra | +46 (0)72 203 6344 |
Redeye is Heliospectra Certified Advisor for Nasdaq First North - www.redeye.se
Heliospectra AB (publ) (OTCQB: HLS, FIRST NORTH: HELIO) is the industry’s most proven intelligent lighting technology for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, growers and commercial producers across six continents use Heliospectra holistic and flexible solutions to consistently increase yields while producing crops that achieve quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Founded in 2006 and winner of multiple international awards and recognitions, Heliospectra has raised more than $32 million in capital to date. As a publicly traded company, the majority ownership remains with some of Heliospectra earliest investors Weland Steel, Swedish Industrial Fund and Midroc New Technology. For more information, please visit https://www.heliospectra.com.
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.00 CEST / 10 AM EDT on July 31, 2017.